These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2998912)

  • 1. A murine model of insulin-dependent diabetes mellitus resulting from the cumulative effects of the nondiabetogenic strain of encephalomyocarditis virus and a single low dose of streptozocin.
    Blay RA; Bigley NJ; Giron DJ
    Diabetes; 1985 Dec; 34(12):1288-92. PubMed ID: 2998912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of diabetes by cumulative environmental insults from viruses and chemicals.
    Toniolo A; Onodera T; Yoon JW; Notkins AL
    Nature; 1980 Nov; 288(5789):383-5. PubMed ID: 6253833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replication of diabetogenic and nondiabetogenic variants of encephalomyocarditis (EMC) virus in ICR Swiss mice.
    Gould CL; Trombley ML; Bigley NJ; McMannama KG; Giron DJ
    Proc Soc Exp Biol Med; 1984 Apr; 175(4):449-53. PubMed ID: 6324221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Encephalomyocarditis virus-induced diabetes mellitus in mice: model of viral pathogenesis.
    Jordan GW; Cohen SH
    Rev Infect Dis; 1987; 9(5):917-24. PubMed ID: 2825321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A genetically determined host factor controlling susceptibility to encephalomyocarditis virus-induced diabetes in mice.
    Kang Y; Yoon JW
    J Gen Virol; 1993 Jun; 74 ( Pt 6)():1207-13. PubMed ID: 8389806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differing attachment of diabetogenic and nondiabetogenic variants of encephalomyocarditis virus to beta-cells.
    Kaptur PE; Thomas DC; Giron DJ
    Diabetes; 1989 Sep; 38(9):1103-8. PubMed ID: 2475377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exacerbation of the pathogenesis of the diabetogenic variant of encephalomyocarditis virus in mice by interferon.
    Gould CL; McMannama KG; Bigley NJ; Giron DJ
    J Interferon Res; 1985; 5(1):33-7. PubMed ID: 3886808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virus-induced murine diabetes. Enhancement by immunosuppression.
    Gould CL; McMannama KG; Bigley NJ; Giron DJ
    Diabetes; 1985 Dec; 34(12):1217-21. PubMed ID: 2998910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental models of insulin-dependent diabetes].
    Bocharov EF; Shestenko OP
    Vopr Virusol; 1986; 31(4):393-400. PubMed ID: 3020804
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of interferons and poly(I):poly(C) on the pathogenesis of the diabetogenic variant of encephalomyocarditis virus in different mouse strains.
    Giron DJ; Agostini HJ; Thomas DC
    J Interferon Res; 1988 Dec; 8(6):745-53. PubMed ID: 2466089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of interferon in the protection of ICR Swiss male mice by the nondiabetogenic variant of encephalomyocarditis virus against virus-induced diabetes mellitus.
    Kaptur PE; Thomas DC; Giron DJ
    J Interferon Res; 1989 Dec; 9(6):671-8. PubMed ID: 2481700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virus-induced diabetes mellitus. XVIII. Inhibition by a nondiabetogenic variant of encephalomyocarditis virus.
    Yoon JW; McClintock PR; Onodera T; Notkins AL
    J Exp Med; 1980 Oct; 152(4):878-92. PubMed ID: 6252275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple low-dose streptozocin-induced diabetes in NOD-scid/scid mice in the absence of functional lymphocytes.
    Gerling IC; Friedman H; Greiner DL; Shultz LD; Leiter EH
    Diabetes; 1994 Mar; 43(3):433-40. PubMed ID: 8314017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of antigenic differences between the diabetogenic and non-diabetogenic variants of encephalomyocarditis virus using monoclonal antibodies.
    Yoon JW; Ko W; Bae YS; Pak CY; Amano K; Eun HM; Kim MK
    J Gen Virol; 1988 May; 69 ( Pt 5)():1085-90. PubMed ID: 2836552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of environmental factors on the development of insulin-dependent diabetes mellitus.
    Yoon JW; Kim CJ; Pak CY; McArthur RG
    Clin Invest Med; 1987 Sep; 10(5):457-69. PubMed ID: 3315367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virus-induced diabetes mellitus. No evidence for immune mechanisms in the destruction of beta-cells by the D-variant of encephalomyocarditis virus.
    Yoon JW; McClintock PR; Bachurski CJ; Longstreth JD; Notkins AL
    Diabetes; 1985 Sep; 34(9):922-5. PubMed ID: 2993085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible mechanisms in the pathogenesis of virus-induced diabetes mellitus.
    Yoon JW; Eun HM; Essani K; Roncari DA; Bryan LE
    Clin Invest Med; 1987 Sep; 10(5):450-6. PubMed ID: 2824113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspectives on the role of viruses in insulin-dependent diabetes.
    Yoon JW; Ray UR
    Diabetes Care; 1985; 8 Suppl 1():39-44. PubMed ID: 2996865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of virus-induced diabetes mellitus by interferon is influenced by the host strain.
    Giron DJ; Cohen SJ; Lyons SP; Wharton CH; Cerutis DR
    Proc Soc Exp Biol Med; 1983 Jul; 173(3):328-31. PubMed ID: 6306672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental models of juvenile onset (insulin-dependent) diabetes mellitus.
    Craighead JE
    Monogr Pathol; 1980; 21():166-76. PubMed ID: 6261120
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.